MedPath

TO STUDY THE EFFECT OF SAUBHAGYA SHUNTHI MODAK IN PREVENTION OF DISEASES AFTER DELIEVERY

Phase 2
Conditions
Health Condition 1: O868- Other specified puerperal infections
Registration Number
CTRI/2021/12/038807
Lead Sponsor
DR SHILPI SINGH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PATIENTS OF PRIMIGRAVIDA AND MULTIGRAVIDA

SUTIKA WITH NORMAL DELIVERY AND CAESAREAN SECTIO

Exclusion Criteria

POSTPARTUM HEMORRHAGE,EXTENSIVE PERINEAL TEAR,SUTIKA WHO HAD COMPLICATION DURING DELIEVERY LIKE POSTPARTUM HEMORRHAGE,EXTENSIVE PERINEAL TEAR ETC.HUMAN HAVING ANY CHRONC SYSTEMIC DISORDER.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TO STUDY THE EFFECT OF SAUBHAGYA SHUNHTHI MODAK IN PREVENTION OF ABDOMIINAL PAIN,BACKACHE,DIGESTION WHICH ARE NORMAL SYMPTOM OF SUTIKA.Timepoint: SAUBHAGYA SHUNTHI MODAK WILL BE GIVEN 12GRAM ONCE A DAY WITH MILK IN MORNING. 8 FOLLOW UPS WILL BE TAKEN. 1ST SEVEN FOLLOW UPS WILL BE FOR 7 DAYS AFTER DELIEVERY. 8TH FOLLOW UP WILL BE AFTER 45 DAYS.TOTAL DURATION OF STUDY WILL BE 45 DAYS.
Secondary Outcome Measures
NameTimeMethod
TO EVALUATE THE EFFECT OF SAUBHAGYA SHUNTHI MODAK IN SADYA PRASUTA AVASTHA(PUERPERIUM) EGARDING HER PHYSICAL AND PHYSIOLOGICAL CONDITION.Timepoint: SAUBHAGYA SHUNTHI MODAK WILL BE GIVEN 12GRAM ONCE A DAY WITH MILK IN MORNING. 8 FOLLOW UPS WILL BE TAKEN. 1ST SEVEN FOLLOW UPS WILL BE FOR 7 DAYS AFTER DELIEVERY. 8TH FOLLOW UP WILL BE AFTER 45 DAYS.TOTAL DURATION OF STUDY WILL BE 45 DAYS.
© Copyright 2025. All Rights Reserved by MedPath